/BCTXW
BCTXW Stock - BriaCell Therapeutics Corp.
Healthcare|BiotechnologyNASDAQ
$0.04-9.57%
$0.00 (-9.57%) • Dec 17
43
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.1
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.43
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BCTXW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.04 – $0.04
TARGET (TP)$0.05
STOP LOSS$0.04
RISK/REWARD1:-34.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.92
52W High$0.06
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-107,338 | $-82,583 | $-20,490 | $-19,385 | $-19,441 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-27,386,315 | $-32,808,117 | $-23,272,000 | $-15,289,000 | $-6,973,000 |
| Net Income | $-26,487,421 | $-4,716,430 | $-20,302,000 | $-11,581,000 | $-2,895,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-62.60 | $-42.99 | $-1.74 | $-1.73 | $-0.19 |
Company Overview
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BCTXWBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.36
Q4 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Oct 31, 2023 | — | $0.36 | — | — |
Q2 2023 | Apr 30, 2023 | — | $-315.47 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-765.68 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-315.47 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-1242.25 | — | — |
Q4 2021 | Oct 31, 2021 | — | $58.47 | — | — |
Q3 2021 | Jul 31, 2021 | — | $147.85 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BCTXW
What is BCTXW's current stock price?
BriaCell Therapeutics Corp. (BCTXW) is currently trading at $0.04 per share. The stock has moved -9.57% today.
What is the analyst price target for BCTXW?
No analyst price targets are currently available for this stock.
What sector is BriaCell Therapeutics Corp. in?
BriaCell Therapeutics Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is BCTXW's market cap?
BriaCell Therapeutics Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BCTXW pay dividends?
No, BriaCell Therapeutics Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCELU
Celularity Inc.
$1.45
Mkt Cap: $0.0B
KTTA
Pasithea Therapeutics Corp.
$1.16
Mkt Cap: $0.0B
LIXT
Lixte Biotechnology Holdings, Inc.
$4.32
Mkt Cap: $0.0B
NUWE
Nuwellis, Inc.
$2.16
Mkt Cap: $0.0B
OCEA
Ocean Biomedical, Inc.
$0.00
Mkt Cap: $0.0B
PETV
PetVivo Holdings, Inc.
$1.16
Mkt Cap: $0.0B
PKBO
Peak Bio, Inc.
$0.02
Mkt Cap: $0.0B
SABS
SAB Biotherapeutics, Inc.
$3.99
Mkt Cap: $0.0B
SYRS
Syros Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
VINC
Vincerx Pharma, Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to BCTXW for comparison